ArticleWorld journal of urology2015

Comparison of clinical outcomes between upgraded pathologic Gleason score 3 + 4 and non-upgraded 3 + 4 prostate cancer among patients who are candidates for active surveillance.

Jung Ki Jo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.